![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/22/2934619/0/en/NKGen-Biotech-Receives-Notification-From-Nasdaq-Related-to-Delayed-Quarterly-Report.html
https://www.globenewswire.com/news-release/2024/07/30/2920975/0/en/NKGen-Biotech-Presents-New-Positive-SNK01-Biomarker-Data-at-the-2024-Alzheimer-s-Association-International-Conference.html
https://www.globenewswire.com/news-release/2024/07/18/2915247/0/en/NKGen-Biotech-to-Present-New-Positive-SNK01-Clinical-Trial-Biomarker-Data-at-the-2024-Alzheimer-s-Association-International-Conference.html
https://www.globenewswire.com/news-release/2024/07/15/2913027/0/en/NKGen-Biotech-Appoints-Dr-Marco-Gottardis-to-its-Board-of-Directors.html
https://www.globenewswire.com/news-release/2024/06/12/2897817/0/en/NKGen-Biotech-Presents-Updated-Phase-1-Data-on-SNK02-Allogeneic-NK-Cell-Therapy-for-Solid-Tumors-at-the-6th-Annual-Allogeneic-Cell-Therapies-Summit-2024.html
https://www.globenewswire.com/news-release/2024/06/03/2892223/0/en/NKGen-Biotech-To-Present-Updated-Phase-1-Data-on-SNK02-Allogeneic-NK-Cell-Therapy-in-Solid-Tumors-at-the-6th-Annual-Allogeneic-Cell-Therapies-Summit-2024.html
https://www.globenewswire.com/news-release/2024/05/23/2887701/0/en/NKGen-Biotech-Publishes-Phase-1-Interim-Analysis-Results-of-SNK02-Allogeneic-NK-Cell-Therapy-in-Advanced-Solid-Tumors-at-the-2024-American-Society-of-Clinical-Oncology-ASCO-Annual-.html
https://www.globenewswire.com/news-release/2024/05/20/2884834/0/en/NKGen-Biotech-s-SNK01-NK-Cell-Therapy-Cleared-to-Start-Phase-2-Clinical-Trial-in-Alzheimer-s-Disease.html
https://www.globenewswire.com/news-release/2024/05/16/2883377/0/en/NKGen-Biotech-Announces-Upcoming-Presentation-on-Autologous-NK-Cell-Therapy-at-the-5th-International-Cell-Gene-Therapy-China-Summit-Exhibition.html
https://www.globenewswire.com/news-release/2024/04/29/2871205/0/en/NKGen-Biotech-Announces-FDA-Clearance-of-Investigational-New-Drug-IND-Application-for-SNK01-NK-Cell-Therapy-in-Parkinson-s-Disease.html